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1. Introduction1
Autoimmune hepatitis (AIH) is a chronic disease of un-
known cause and is characterized by chronic liver hepato-
cellular inflammation and necrosis and has a tendency to 
progress to cirrhosis. High gammaglobulin hyperlipidemia 
with the present of serum autoantibodies will cause his-
tological change of the liver. Some studies approved that 
cytokines and immune cells, genetic background, immune 
regulation network and other factors may cause damage to 
the liver cells [1]. The disease occurred in the whole world, 
the incidence of the disease in Europe and the United 
States is higher, the AIH reports in China are rare, but the 
trend is rising year by year. The disease is more common in 
women, male and female where the ratio is 1:4, any age can 
be at the age of 50 years old. However, severe cases such as 
non-timely treatment causing 6 months of high mortality 
rate of 40% [2]. In this study, 43 cases of autoimmune hep-
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atitis were retrospectively analyzed, and to explore the ef-
ficacy and safety of pure plasma exchange in the treatment 
of AIH.
2. Materials and methods
2.1. General information
In our hospital from March 2011 to March 2015, there are 
43 patients with AIH were treated and were selected as the 
research object. Among them 9 cases were male, account-
ing for 20.93%, 34 cases of female accounting for 79.07%. 
The age of the patients are range from 28 to 65 years old, 
with average age (45.5 + 2.5) years old. Clinical manifes-
tation: abdominal distension, fatigue, loss of appetite and 
jaundice. Inclusion criteria: (1) By clinical diagnosis for 
severe autoimmune hepatitis person; (2) Without renal 
failure; (3) Coagulation dysfunction; (4) Operative toler-
ance and agreed to the project. Exclusion criteria: Patients 
with severe autoimmune hepatitis complicated with hyper-
tension and diabetes mellitus. The patients were randomly 
divided into PE group (22 cases) and control group (21 
cases) with the approval of the ethics committee and the 
consent of patients. The gender, age, symptoms and clini-
cal manifestations of the two groups were not statistically 
significant (p > 0.05).
2.2. Inspection and diagnosis
A total of 25 patients were treated with 48h in the diagno-
sis and treatment where the clinical examination results 
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were as follows; liver function for hepatitis B changes, a 
globulin or IgG rise which is greater or equal to 1.5 times 
than the normal limit;. Antibodies of patients with anti-
nuclear antibody (ANA) positive, flat rate 75%, muscle an-
tibodies (SMA) positive, some patients appear extrahepatic 
autoimmune diseases. The pathological changes of the 
patients were examined by histopathological examination, 
such as the changes of the liver and the appearance of the 
leaf, the change of the rose and the necrosis of the bridge. 
According to the 2002 American Institute, the diagnosis of 
liver diseases can be diagnosed as autoimmune hepatitis 
[3].
2.3. Method
This retrospective study included clinical data of 43 pa-
tients with severe autoimmune hepatitis (AIH) were evalu-
ated by retrospective clinical data analysis, and combined 
with the research data of domestic and foreign scholars and 
the effect of single plasma exchange (PE) in the treatment 
of autoimmune hepatitis (AIH) was discussed. According 
to the actual situation of the patient’s body first, the control 
group was treated with medical therapy where the patients 
need to take anti-inflammatory drugs, such as Transmetil. 
After that, taking nucleoside analogue drugs (ADV, ETV, 
and LAM) for antiviral therapy while transplantation sur-
gery can be implemented for severe cases of liver disease. 
On the other hand, for PE group, the group is on the basis 
of the implementation of the pure blood plasma replace-
ment therapy. Implementation of deep vein catheterization 
was applied to the patient according to the static pulse and 
the actual situation of the body. Plasma exchange param-
eters are as follows: blood flow 90 mL to 1000 mL of hepa-
rin saline (containing 50 mg heparin), plasma exchange 
amount 2500 mL of management for flushing heparin to 
maintain the volume 5 mg/h. The Asahi medical COLTD-
Plasauto iQ21 type hemodialysis machine (Japanese rising 
sun Medical Corporation production) was used.
2.4. Observation index
Two groups of patients were examined based on the cura-
tive effect, the final cure rate, average hospitalization days, 
etc, after 2 weeks treatment of different treatment regi-
mens. 
2.5. Statistical methods
All the statistical analysis of the data was statistically ana-
lyzed by SPSS 17.0 software. Continuous data were ex-
pressed as mean ± standard deviation ( x  ± s). Student t 
test analyses for comparison between groups, all were done 
as 2-sided tests, when p < 0.05 was considered statistically 
significant.
3. Results
3.1. Biochemical indexes in two groups
The change of biochemical index after the simple plasma 
exchange is the best index to evaluate the treatment ef-
fect. There were significant differences before and after (p 
< 0.01) in TBiL treatment while AST and ALT were also 
significantly different before and after treatment (p < 0.05). 
However, in the TNR index, there was not statistically sig-
nificant (p > 0.05) before and after treatment. The results of 
data analysis and statistical analysis show that pure plasma 
exchange has a certain effect on the treatment of autoim-
mune hepatitis, as shown in Table 1.
3.2. Comparison of clinical efficacy between the two 
groups
For patients with autoimmune hepatitis, simple plasma 
exchange is a better therapy. The results showed that the 
effective rate of PE group was 77.27% (17/22), while the 
control group was 47.62% (10/21), the difference was sta-
tistically significant (p < 0.05), as shown in Table 2.
4. Discussion
Autoimmune hepatitis is a kind of chronic inflammatory 
Table 1. Changes of biochemical parameters in patients with severe autoimmune hepatitis treated by simple plasma exchange ( ~x  
± s).
Treatment method TBiL (umol/L) ALT (U/L) AST (U/L) INR
PE before treatment (n = 22) 573.21 ± 161.98 158.37 ± 179.38 118.79 ± 98.39 2.17 ± 0.19
After PE treatment (n = 22) 308.12 ± 117.26 71.99 ± 61.20 59.18 ± 7.97 1.53 ± 0.27
t 8.554 8.954 8.325 1.029
p < 0.001 < 0.05 < 0.05 > 0.05
Table 2. Comparison of clinical efficacy between the two groups [n (%)].
Group n Cure Effective Invalid Total effective (%)
PE group 22 12 (54.55) 5 (22.73) 5 (22.73) 77.27
Control group 21 3 (14.29) 7 (33.33) 11 (52.38) 47.62
χ2 - 7.667 0.601 4.044 18.744
p - < 0.05 > 0.05 > 0.05 < 0.05
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disease of liver. According to the clinical research in the 
current medical field, the main clinical manifestations of 
this disease are different degrees of serum aminotrans-
ferase, immunoglobulin, and self-antibody ; the histologi-
cal features of lymphocytes and plasma cells infiltration of 
the main interface hepatitis. Severe autoimmune hepatitis 
can rapidly progress to cirrhosis or liver failure. The inci-
dence of autoimmune hepatitis in the whole world is at a 
high level, especially in Europe and the United States. The 
incidence and prevalence of this disease is not yet a sys-
tematic statistic.
Simple plasmapheresis is a process in which plasma 
components are removed from the blood, such as autoan-
tibodies, that can cause autoimmune disease. The separa-
tion of blood of the patients with autoimmune hepatitis 
was mainly accomplished by automatic blood cell separa-
tor where separated the pathological antigen, antibody, 
immune complexes, protein, inflammatory mediators and 
toxins. After purification of blood the plasma with recon-
stituted treatment were returned back to the patients. The 
application in conventional therapy object was mainly 
concentrated whether the patient cannot get ideal effect 
or invalid in critically ill patients. Plamapheresis is an ef-
fective treatment in order to extend the life of patients and 
improve quality of life [4].
In the PE group, 22 cases were cured, the cure rate was 
77.27% while in the control group was 21 cases and the 
cure rate was 47.62%. The effect of simple plasma exchange 
(PE) on the treatment of autoimmune hepatitis (AIH) is 
better than that of the conventional treatment. But the 
simple operation of plasma exchange (PE) may cause rash, 
face, lips, numbness or seizures, and anaphylactic shock 
adverse reaction. The most adverse reactions are improper 
operation, where anti-allergy measures adverse and in-
dication of the uncertainty [5,6]. Therefore, the use of 
timely prevention and treatment are an effective ways 
where the majority of adverse reactions can be avoided 
and eliminated.
Currently, there are no specific drugs can be used to 
cured autoimmune hepatitis. For the moment, pure plas-
ma exchange is the most extensive and effective method of 
treatment in combating the autoimmune diseases. How-
ever, there will be a series of complications after treatment, 
so comprehensive evaluation of patients’ physical quality 
and the collection of patients and family members should 
be examined before the use of modified method in treat-
ment.
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